The Zhitong Finance App learned that on Thursday, the pharmaceutical sector strengthened against the market. AstraZeneca (AZN.US), BMY.US (LLY.US) rose more than 4%, GlaxoSmithKline (GSK.US), Novo Nordisk (NVO.US), and Novartis Pharmaceuticals (NVS.US) rose more than 3%, and Pfizer (PFE.US) and MSD (MRK.US) rose more than 2%.

The analysis points out that as the US CPI data for September exceeded expectations, market concerns about the Fed's interest rate hike heated up, and the AI hardware sector experienced large-scale sell-off. After risk appetite declined, capital was rotated to defensive sectors such as pharmaceuticals.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.